Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:
OTC Drugs

P&G's 3D White Spurs Crest Market Share Gains

This article was originally published in The Tan Sheet

  • News

Executive Summary

Sales of Procter & Gamble's Crest 3D White toothpaste offset the continued decline of Prilosec OTC proton pump inhibitor sales as the firm reports flat health care division revenue for its latest quarter.

You may also be interested in...



P&G Launches Oral Care "Crusade" To Build On Leading U.S. Market Share

Procter & Gamble uses social media to promote its 4X Cleaner Crusade grassroots effort that targets improving oral health and promoting its Crest and Oral-B products.

Colgate ProClinical Lands As Latest Innovation In Slumping Oral Care Market

Colgate-Palmolive's unveiling of Colgate ProClinical toothpaste is the latest of many launches in an increasingly competitive segment of the personal care market as firms ramp up product development to spur growth

Bridges Consumer Startup Reaches Brands For Specialty Conditions In Clarion Deal

Acquiring Clarion Brands from Swander Pace, Bridges Consumer Healthcare adds portfolio of OTC and supplement brands for symptoms including tinnitus, urinary pain relief and excessive sweating.

Table

View full table

Topics

Tags:
OTC Drugs
UsernamePublicRestriction

Register

RS150923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By